Copyright
©The Author(s) 2021.
World J Clin Cases. Apr 26, 2021; 9(12): 2721-2730
Published online Apr 26, 2021. doi: 10.12998/wjcc.v9.i12.2721
Published online Apr 26, 2021. doi: 10.12998/wjcc.v9.i12.2721
Subjects | All lung cancer patients, n = 106 | Lung cancer patients presenting as GGO, n = 42 | |||||
AUC | P value | Sensitivity | AUC | P value | Sensitivity | Specificity | |
Total CTCs | 0.828 | < 0.0001 | 79.24% | 0.7963 | < 0.0001 | 71.42% | 82.14% |
E-CTCs | 0.6193 | 0.0527 | 50.00% | 0.6029 | 0.1469 | 47.62% | 71.43% |
M-CTCs | 0.6892 | 0.0021 | 49.05% | 0.6722 | 0.0152 | 42.85% | 89.29% |
E&M-CTCs | 0.7648 | < 0.0001 | 69.80% | 0.7504 | 0.0004 | 66.67% | 82.14% |
Total CTCs and E&M-CTCs | 85.85% | 80.95% | 78.57% |
- Citation: Jiang SS, Mao CG, Feng YG, Jiang B, Tao SL, Tan QY, Deng B. Circulating tumor cells with epithelial-mesenchymal transition markers as potential biomarkers for the diagnosis of lung cancer. World J Clin Cases 2021; 9(12): 2721-2730
- URL: https://www.wjgnet.com/2307-8960/full/v9/i12/2721.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i12.2721